Bryn Mawr Capital Management LLC Has $369,000 Stock Position in Maximus, Inc. (NYSE:MMS)

Bryn Mawr Capital Management LLC raised its holdings in Maximus, Inc. (NYSE:MMS) by 129.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 4,946 shares of the health services provider’s stock after acquiring an additional 2,794 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Maximus were worth $369,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. increased its position in Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 158 shares during the period. Eastern Bank acquired a new position in Maximus in the 4th quarter valued at approximately $29,000. V Square Quantitative Management LLC increased its position in Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after acquiring an additional 180 shares during the period. R Squared Ltd acquired a new position in Maximus in the 4th quarter valued at approximately $54,000. Finally, IFP Advisors Inc increased its position in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after acquiring an additional 302 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Michelle F. Link sold 2,208 shares of the stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

MMS has been the topic of a number of analyst reports. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Maximus Trading Down 0.5 %

NYSE:MMS opened at $66.43 on Friday. The firm’s fifty day moving average is $73.45 and its 200-day moving average is $81.14. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a 52 week low of $64.53 and a 52 week high of $93.97. The firm has a market cap of $3.76 billion, a P/E ratio of 14.29 and a beta of 0.72.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.81%. The ex-dividend date of this dividend is Friday, February 14th. Maximus’s dividend payout ratio is presently 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.